Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.
Teitur Trophics has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
Teitur Trophics's investors include Innovestor, Sound Bioventures, Sunstone Life Science Ventures, Industrifonden, p53.
Teitur Trophics is headquartered in Aarhus, Denmark.
Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.
Teitur Trophics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Teitur Trophics — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/teitur-trophics. Accessed October 30, 2026.
VCBacked. (2023). Teitur Trophics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/teitur-trophics
{{cite web |title=Teitur Trophics — Funding & Investors |url=https://www.vcbacked.co/company/teitur-trophics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated